Technologies related to NEI

Sterculic Acid Treatment for Choroidal Neovascularization
Ref: E-092-2010 | Updated: Aug 31, 2016
Selective Estrogen-Receptor Modulators (SERMs) Confer Protection Against Photoreceptor Degeneration
Ref: E-134-2016/0 | Updated: Jun 22, 2017
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
Ref: E-134-2016 | Updated: Jun 22, 2017
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016/0 | Updated: Apr 18, 2017
Devices for Improved Tissue Cryopreservation and Recovery
Ref: E-094-2016 | Updated: Apr 14, 2017
Transgenic Mouse Model of Human Open Angle Glaucoma
Ref: E-091-2015/0 | Updated: Jul 2, 2015
IFN Gamma for Reducing Adverse Ocular Side Effects of MEK-Inhibitor Therapy in Cancer
Ref: E-248-2012/0 | Updated: Jul 1, 2015
Ex-vivo Production of Regulatory B-Cells (Breg) for Use in Auto-immune Indications
Ref: E-036-2012/0 | Updated: Apr 15, 2014
Surgical Tool for Ocular Tissue Transplantation
Ref: E-105-2013/0 | Updated: Nov 13, 2013
Novel Methods for Generating Retinal Pigment Epithelium Cells from Induced Pluripotent Stem Cells
Ref: E-251-2012/3 | Updated: May 31, 2013
Methods of Treating Age-Related Macular Degeneration
Ref: E-099-2010/0 | Updated: Mar 29, 2011
Use of Sterculic Acid to Treat Choroidal Neovascularization
Ref: E-092-2010/0 | Updated: Jan 24, 2018
Nitisinone for Treatment of Oculocutaneous/Ocular Albinism and for Increasing Pigmentation
Ref: E-113-2010/0 | Updated: Jan 6, 2011
Immortalized Transformed Lymphoblastoid Cell Lines from Patients with François-Neetens Mouchetée Fleck Corneal Dystrophy (CFD)
Ref: E-270-2009/0 | Updated: Sep 23, 2009
Treatment and Prevention of Age-Related Macular Degeneration and Other Eye-Related Diseases
Ref: E-056-2008/0 | Updated: Nov 1, 2008
Methods for Using Interferon Gamma to Absorb Fluid From the Subretinal Space
Ref: E-169-2008/0 | Updated: Nov 1, 2008
Identification and Isolation of the Receptor for Pigment Epithelium-derived Factor (PEDF)
Ref: E-314-2003/0 | Updated: Mar 1, 2007
Devices for Aseptic Lyophilization of Biological Samples
Ref: E-015-1995/2 | Updated: Sep 1, 2006
cDNA for Murine PEDF
Ref: E-112-2004/0 | Updated: Mar 6, 2017
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Ref: E-008-2004/0 | Updated: Mar 6, 2017
Ocular Therapeutic Agent Delivery Devices And Methods
Ref: E-241-1999/0 | Updated: May 1, 2001
Immunoadhesins and Methods of Production Thereof
Ref: E-127-1996/0 | Updated: Jul 1, 1999
Animal Model for Age-Related Macular Degeneration and Methods for Use Thereof
Ref: E-078-1997/0 | Updated: Sep 1, 1998
Macrophage Migration Inhibitory Factor (MIF)
Ref: E-090-1991/0 | Updated: May 1, 1997
Pigment Epithelium Derived Factor: Characterization of Its Novel Biological Activity and Sequences Encoding and Expressing the Protein
Ref: E-185-1992/1 | Updated: Jul 1, 1996
Subscribe to Technologies related to NEI